Martine Rothblatt

2017

In 2017, Martine Rothblatt earned a total compensation of $37.1M as Chairman and Chief Executive Officer at United Therapeutics, a 141% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,239,653
Non-Equity Incentive Plan$1,598,163
Option Awards$33,122,078
Salary$1,163,707
Other$9,600
Total$37,133,201

Rothblatt received $33.1M in option awards, accounting for 89.20% of the total pay in 2017.

Rothblatt also received $1.2M of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $1.2M in salary and $9.6K in other compensation.

Rankings

In 2017, Martine Rothblatt's compensation ranked 42nd out of 14,017 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.7% of executives.

ClassificationRankingPercentile
All
42
out of 14,017
100th
Division
Manufacturing
7
out of 5,547
100th
Major group
Chemicals And Allied Products
2
out of 1,968
100th
Industry group
Drugs
2
out of 1,632
100th
Industry
Pharmaceutical Preparations
2
out of 1,256
100th
Source: SEC filing on April 27, 2018.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2017.

2017

Paul Mahon

United Therapeutics

General Counsel

2017

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2017

James Edgemond

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like